Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to pre-eclampsia

Hypertension Research

Volumn 35, Issue 12, 2012, Pages 1129-1134

  Xia, Xiao Ping ^a,b   Chang, Wei Wei ^c   Cao, Yun Xia ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Department of Gynecology and Obstetrics   (China)

^c WANNAN MEDICAL COLLEGE   (China)

Author keywords

methylenetetrahydrofolate reductase; MTHFR C677T; polymorphism

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ALLELE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MEDLINE; PREECLAMPSIA; PREGNANT WOMAN; REVIEW; SYSTEMATIC REVIEW;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PUBLICATION BIAS;

EID: 84870824739     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.117     Document Type: Review

References (64)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-799.
2. Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia.Clin Sci 2006; 110: 443-458.
3. Goddard KA, Tromp G, Romero R, Olson JM, Lu Q, Xu Z, Parimi N, Nien JK, Gomez R,Behnke E, Solari M, Espinoza J, Santolaya J, Chaiworapongsa T, Lenk GM, VolkenantK, Anant MK, Salisbury BA, Carr J, Lee MS, Vovis GF, Kuivaniemi H. Candidate geneassociation study of mothers with pre-eclampsia, and their infants,analyzing 775 SNPsin 190 genes. Hum Hered 2007; 63: 1-16.
4. Parimi N, Tromp G, Kuivaniemi H, Nien JK, Gomez R, Romero R, Goddard KA.Analytical approaches to detect maternal/fetal genotype incompatibilities that increaserisk of pre-eclampsia. BMC Med Genet 2008; 9: 60.
5. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH,den Heijer M, Kluijtmans LAJ, van den Heuve LP, Rozen RA. candidate geneticrisk factor for vascular disease: a common mutation in methylenetetrahydrofolatereductase. Nat Genet 1995; 10: 111-113.
6. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia andrecurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000; 74: 1196-1199.
7. Kupferminc MJ. Thrombophilia and pregnancy. Curr Pharm Des 2005; 11: 735-748.
8. Eskes TK. Clotting disorders and placental abruption: homocysteine-A new risk factor.Eur J Obstet Gynecol Reprod Biol 2001; 95: 206-212.
9. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL,Ueland PM. Plasma total homocysteine, pregnancy complications, and adversepregnancy out-comes: the Hordaland Homocysteine study. Am J Clin Nutr 2000; 71:962-968.
10. Kosmasa IP, Tatsioni A, Ioannidis JPA. Association of C677T polymorphism in themethylenetetrahydrofolate reductase gene with hypertension in pregnancy and preeclampsia:A meta-analysis. J Hypertens 2004; 22: 1655-1662.
11. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospectivestudies of disease. J Natl Cancer Inst 1959; 22: 719-748.
12. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: anupdate. Contemp Clin Trials 2007; 28: 105-114.
13. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med2002; 21: 1539-1558.
14. Rigo J, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, Papp Z. Maternal and neonataloutcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutationand 5,10 methylenetetrahydrofolate reductase. Hypertens Pregn 2000; 19:163-172.
15. Livingstone JC, Barton JR, Park V, Haddad B, Philips O, Sibai BM. Maternal and fetalinherited thrombophilias are not related to the development of severe preeclampsia.Am J Obstet Gynecol 2001; 185: 153-157.
16. Wang SM, Wang LG, Liu XJ, Wu AH, Yu JC, Shi H. Investigation on the associationbetween MTHFR gene C677T polymorphism and pre-eclampsia. Maternal and ChildHealth Care of China 2008; 23: 552-554.
17. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, Fitzgerald DJ.Prospective evaluation of the risk conferred by factor V Leiden and thermolabilemethylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler ThrombVasc Biol 2000; 20: 266-270.
18. Kaiser T, Brennecke SP, Moses EK. Methylenetetrahydrofolate reductase polymorphismsare not a risk factor for pre-eclampsia/eclampsia in Australian women. GynecolObstet Invest 2000; 50: 100-102.
19. Kaiser T, Brennecke SP, Moses EK. C677T methylenetetrahydrofolate reductasepolymorphism is not a risk factor for pre-eclampsia/eclampsia among Australianwomen. Hum Hered 2001; 51: 20-22.
20. Raijmakers MT, Zusterzeel PL, Steegers EA, Peters WH. Hyperhomocys-teinaemia:A risk factor for preeclampsia? Eur J Obstet Gynecol Reprod Biol 2001; 95:226-228.
21. Zusterzeel PL, Visser W, Blom HJ, Peters WH, Heil SG, Steegers EA. Methylenetetrahydrofolatereductase polymorphisms in pre-eclampsia and the HELLP syndrome.Hypertens Pregnancy 2000; 19: 299-307.
22. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolatereductase polymorphism and pre-eclampsia. J Med Genet 1997; 34:525-526.
23. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P,Montanaro S, Pavone G, Di Minno G. The factor V Leiden, C.T MTHFRpolymorphism and genetic susceptibility to pre-eclampsia. Thromb Haemost 1997;77: 1052-1054.
24. Chikosi AB, Moodley J, Pegoraro RJ, Lanning PA, Rom L. 5,10 methylenetetrahydrofolatereductase polymorphism in black South African women with pre-eclampsia.Br J Obstet Gynaecol 1999; 106: 1219-1220.
25. O'Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH. F actor V Leidenand thermolibile methylenetetrahydrofolate reductase gene variants in an East Anglianpreeclampsia cohort. Hypertension 1999; 33: 1338-1341.
26. Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR, Roberts JM.Methylenetetrahydrofolate reductase polymorphism,folate,and susceptibility to preeclampsia.J Soc Gynecol Investig 1999; 6: 74-79.
27. Kobashi G, Yamada H, Asano T, Nagano S, Hata A, Kishi R, Fujimoto S, Kondo K.Absence of association between a common mutation in the methylenete-trahydrofolatereductase gene and preeclampsia in Japanese women. Am J Med Genet 2000; 93:122-125.
28. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K. 677 C-T polymorphism ofthe methylenetetrahydrofolate reductase gene and pre-eclampsia. Obstet Gynecol2000; 96: 277-280.
29. Li K, Zheng D, Xue Y, Sun Y, Chen L, Guo J, Zhang G, Li P. The common C677Tpolymorphism in the methylenetetrahydrofolate reductase gene is associated withneural tube defects and preeclampsia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2000;17: 76-78.
30. Rajkovic A, Mahomed K, Rozen R, Malinow MR, King IB, Williams MA. Methylenetetrahydrofolatereductase 677 C-T polymorphism, plasma folate, vitamin B (12)concentrations, and risk of preeclampsia among black African women from Zimbabwe.Mol Genet Metab 2000; 69: 33-39.
31. Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ, Merrill DC.Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution atnucleotide 677 of the gene for methylenete-trahydrofolate reductase, 68-base pairinsertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor VLeiden mutation. Am J Obstet Gynecol 2001; 184: 1211-1217.
32. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Pals G, ten Kate LP, de Vries JI,Kostense PJ, Aarnoudse JG, Dekker GA. Mutations in the gene for methylenetetrahydrofolatereductase, homocysteine levels, and vitamin status in women with a history ofpreeclampsia. Am J Obstet Gynecol 2001; 184: 394-402.
33. Watanabe H, Hamada H, Yamakawa-Kobayashi K, Yoshikawa H, Arinami T. Evidencefor an association of the R485K polymorphism in the coagulation factor V gene withsevere preeclampsia from screening 35 polymorphisms in 27 candidate genes. ThrombHaemost 2001; 86: 1594-1595.
34. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS,Greaves M, Vickers MA. Prothrombotic genotypes are not associated with preeclampsiaand gestational hypertension: results from a large population-based studyand systematic review. Thromb Haemost 2002; 87: 779-785.
35. Prasmusinto D, Skrablin S, Hofstaetter C, Fimmers R, van der Ven K. Themethylenetetrahydrofolate reductase 677 C-T polymorphism and pre-eclampsia intwo populations. Obstet Gynecol 2002; 99: 1085-1092.
36. De Maat MP, Jansen MW, Hille ET, Vos HL, Bloemenkamp KW, Buitendijk S,Helmerhorst FM, Wladimiroff JW, Bertina RM, De Groot CJ. Preeclampsia and itsinteraction with common variants in thrombophilia genes. J Thromb Haemost 2004;2: 1588-1593.
37. Perez-Mutul J, Gonzalez-Herrera L, Sosa-Cabrera T, Mart?́nez- Olivares R. A mutation inthe 5, 10-methylenetetrahydrofolate reductase gene is not associated with preeclampsiain women of southeast Mexico. Arch Med Res 2004; 35: 231-234.
38. Pegoraro RJ, Chikosi A, Rom L, Roberts C, Moodley J. Methylenetetrahydrofolatereductase gene polymorphisms in black South Africans and the association withpreeclampsia. Acta Obstet Gynecol Scand 2004; 83: 449-454.
39. Williams MA, Sanchez SE, Zhang C, Bazul V. Methylenetetrahydrofolate reductase 677C-T polymorphism and plasma folate in relation to pre-eclampsia risk amongPeruvian women. J Matern Fetal Neonatal Med 2004; 15: 337-344.
40. Yilmaz H, Unlüçerçi Y, Gü rdö l F, Isbilen E, Isbir T. Association of pre-eclampsia withhyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677Tpolymorphismin a Turkish population. Aust N Z J Obstet Gynaecol 2004; 44:423-427.
41. Also-Rallo E, Lopez-Quesada E, Urreizti R, Vilaseca MA, Lailla JM, Balcells S, GrinbergD. Polymorphisms of genes involved in homocysteine metabolism in preeclampsiaand in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol 2005; 120:45-52.
42. Davalos IP, Moran MC, Martinez-Abundis E, González-Ortiz M, Flores-Mart?́nez SE,Machorro V, Sandoval L, Figuera LE, Mena JP, Oliva JM, Tlacuilo-Parra JA, Sánchez-Corona JSalazar-Páramo M. Methylenetetrahydrofolate reductase C677T polymorphismand Factor V Leiden variant in Mexican women with preeclampsia/eclampsia. BloodCells Mol Dis 2005; 35: 66-69.
43. Dalmaz CA, Santos KG, Botton MR, Tedoldi CL, Roisenberg I. Relationship betweenpolymorphisms in thrombophilic genes and preeclampsia in a Brazilian population.Blood Cells Mol Dis 2006; 7: 107-110.
44. Jääskeläinen E, Keski-Nisula L, Toivonen S, Romppanen EL, Helisalmi S, Punnonen K,Heinonen S. MTHFR C677T polymorphism is not associated with placental abruptionor preeclampsia in Finnish women. Hypertens Pregnancy 2006; 25: 73-80.
45. Dusse LM, Carvalho MG, Braganca WF, Paiva SG, Godoi LC, Guimarães DA, FernandesAP. Inherited thrombophilias and pre-eclampsia in Brazilian women. Eur J ObstetGynecol Reprod Biol 2007; 34: 20-23.
46. Nagy B, Hupuczi P, Papp Z. High frequency of methylenetetrahydrofolate reductase677TT genotype in Hungarian HELLP syndrome patients determined by quantitativereal-time PCR. J Hum Hypertens 2007; 21: 154-158.
47. Zhang ZH, Zhang RJ, Liu AM, Xu X, Liu ZH. Study on eNOS gene and MTHFR genepolymorphisms in preeclampsia. J Birth Health Hered 2007; 15: 21-23.
48. Canto P, Canto-Cetina T, Juárez-Velázquez R, Rosas-Vargas H, Rangel-Villalobos H,Canizales-Quinteros S, Velázquez-Wong AC, Villarreal-Molina MT, Fernández G, Coral-Vázquez R. Methylenetetrahydrofolate reductase C677T and glutathione S-transferaseP1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women.Hypertens Res 2008; 31: 1015-1019.
49. Muetze S, Leeners B, Ortlepp JR, Kuse S, Tag CG, Weiskirchen R, Gressner AM,Rudnik-Schoeneborn S, Zerres K, Rath W. Maternal factor V Leiden mutation isassociated with HELLP syndrome in Caucasian women. Acta Obstet Gynecol Scand2008; 87: 635-642.
50. Zhang XY, Sun D, Sun J. The relationship between plasma homocysteine andpreeclampsia. J Perinat Med 2008; 114: 245-248.
51. Shen XN, Huang YP, Tang SH, Zhang CL, Chen WS. The relationship between thepolymorphism of MTHFR gene and pre-eclampsia. J Pract Obstet Gynecol 2009; 25:236-238.
52. Stiefel P, Miranda ML, Bellido LM, Luna J, Jiménez L, Pamies E, de Frutos PG, Villar J.Genotype of the CYBA promoter-930A/G, polymorphism C677T of the MTHFR andAPOE genotype in patients with hypertensive disorders of pregnancy: an observationalstudy. Med Clin, 2009; 133: 657-661.
53. Aggarwal S, Dimri N, Tandon I, Agarwal S. Pre-eclampsia in North Indian women: thecontribution of genetic polymorphisms. J Obstet Gynaecol Res 2011; 37: 1335-1341.
54. Report of the National High Blood Pressure Education Program Working Group on highblood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
55. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes ofmaternal death: A systematic review. Lancet 2006; 367: 1066-1074.
56. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelaeof preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008;156: 918-930.
57. Wen SW, Chen XK, Rodger M, Rennicks White R, Yang Q, Smith GN, Sigal RJ, PerkinsSL, Walker MC. Folic acid supplementation in early second trimester and the risk ofpreeclampsia. Am J Obstet Gynecol 2008; 198: e41-e47.
58. Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet2010; 376: 631-644.
59. López-Jaramillo P, Casas JP, Serrano N. Pre-eclampsia:from epidemiological observationsto molecular mechanisms. Braz J Med Biol Res 2001; 34: 1227-1235.
60. Lopez-Quesada E, Vilaseca MA, Lailla JM. Plasma total homocysteine in uncomplicatedpregnancy and in preec-lampsia. Eur J Obstet Gynecol Reprod Biol 2003;108: 45-49.
61. Fletcher O, Kessling AM. MTHFR association with arteriosclerotic vascular disease?Hum Genet 1998; 103: 11-21.
62. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, Seligsohn U. Thefrequent 5,10-methylenetetrahydrofolate reductase C677T polymorphismis associatedwith a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 2002;70: 758-762.
63. Sadewa AH, Sutomo RS, Hayashi C, Lee MJ, Ayaki H, Sofro AS, Matsuo M, Nishio H.The C677T mutation in the methylenetetrahydrofolate reductase gene among theIndonesian Javanese population. Kobe J Med Sci 2002; 48: 137-144.
64. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinicalimplications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22:195-201.